Cancer and ageing: rival demons?
The DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
Abstract
Organisms with renewable tissues use a network of genetic pathways and cellular responses to prevent cancer. The main mammalian tumour-suppressor pathways evolved from ancient mechanisms that, in simple post-mitotic organisms, act predominantly to regulate embryogenesis or to protect the germline. The shift from developmental and/or germline maintenance in simple organisms to somatic maintenance in complex organisms might have evolved at a cost. Recent evidence indicates that some mammalian tumour-suppressor mechanisms contribute to ageing. How might this have happened, and what are its implications for our ability to control cancer and ageing?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several lines of evidence indicate that cellular senescence is a potent tumor-suppressive mechanism [ 4 , 9 , 10 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [10]
In the citing paper
“Despite support for the idea that senescence is a beneficial anticancer mechanism, indirect evidence suggests that senescent cells can also be deleterious and might contribute to age-related pathologies [ 10 , 23 – 25 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [10]
In the citing paper
“It is a cellular program which acts as a double-edged sword, with both beneficial and detrimental effects on the health of the organism, and considered to be an example of evolutionary antagonistic pleiotropy.”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Campisi, 2003
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Apoptosis in the Pathogenesis and Treatment of Disease
Thompson, C. B. (1995) · Science · doi:10.1126/science.7878464 · Cited by 6,524 · cited 1×
“Apoptosis and ageing How might apoptosis contribute to ageing? In the somatic tissues of adult complex organisms, apoptosis is important for maintaining tissue homeostasis; defective apoptosis (either too little or too much) is associated with a number of disease”
BackgroundCDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Pleiotropy, natural selection, and the evolution of senescence.
Williams, G. C. (1957) · Evolution · doi:10.1111/j.1558-5646.1957.tb02911.x · Cited by 4,279
The regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
The microenvironment of the tumour–host interface
Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,310
Research works printed but not linked: 2
- Prives, C. & Hall, P. A. The p53 pathway. J. Pathol. 187, 112–126 (1999). · doi:10.1002/(sici)1096-9896(199901)187:1<112::aid-path250>3.0.co;2-3
- Davenport, J. Tumor-free but not in the clear. Science, SAGE–KE, 2002.
Cited by
Items 101–200 of 511
Hsp90 inhibitors as senolytic drugs to extend healthy aging
Fuhrmann-Stroissnigg, H., Niedernhofer, L. J., & Robbins, P. D. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1475828 · Cited by 92
“development, wound healing and cancer prevention, but being detrimental at older ages as the damaging, senescent cell burden increases [3].”
BackgroundDiscovery of co-occurring driver pathways in cancer
Zhang, J., Wu, L.-Y., Zhang, X.-S., & Zhang, S. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-271 · Cited by 90
“This figure was adapted/extracted according to [31,32].”
Blasiak, J., Piechota, M., Pawlowska, E., Szatkowska, M., Sikora, E., & Kaarniranta, K. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/5293258 · Cited by 90
“Although we believe that senescent cells accumulate with age partially due to their resistance to apoptosis [31], one cannot exclude that at least some of them are cleared by the immune system, as recently reported [32] or that in certain circumstances they can die.”
Molecular Mechanisms Involved in the Aging of the T-cell Immune Response
Antonio Moro-Garcia, M., Alonso-Arias, R., & Lopez-Larrea, C. (2012) · Current Genomics · doi:10.2174/138920212803759749 · Cited by 88
p53/MDM2 signaling pathway in aging, senescence and tumorigenesis
Huang, Y., Che, X., Wang, P. W., & Qu, X. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.05.001 · Cited by 94
Versatile functions of p53 protein in multicellular organisms
Chumakov, P. M. (2007) · Biochemistry (Moscow) · doi:10.1134/s0006297907130019 · Cited by 84
Jansen, S. W., Akintola, A. A., Roelfsema, F., van der Spoel, E., Cobbaert, C. M., Ballieux, B. E., Egri, P., Kvarta-Papp, Z., Gereben, B., Fekete, C., et al. (2015) · Scientific Reports · doi:10.1038/srep11525 · Cited by 82
Bin1 Ablation Increases Susceptibility to Cancer during Aging, Particularly Lung Cancer
Chang, M. Y., Boulden, J., Katz, J. B., Wang, L., Meyer, T. J., Soler, A. P., Muller, A. J., & Prendergast, G. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1100 · Cited by 67
“Some tumor suppressor genes exhibit antagonistic pleiotropy, supporting fitness early in life but at a later cost to aging that exerts little evolutionary impact because the deficits accrue after reproduction is complete ( 36 ).”
BackgroundPlatz, E. A., Kulaç, İ., Barber, J. R., Drake, C. G., Joshu, C. E., Nelson, W. G., Lucia, M. S., Klein, E. A., Lippman, S. M., Parnes, H. L., et al. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0503 · Cited by 87
“To test for trend, we used an ordinal term for proportion of cores with inflammation [none (0), some (1), all (2) cores] ormean percentage of tissue area with inflammation [none (0), tertile 1 (1), tertile 2 (2), tertile 3 (3)] and evaluated the coefficient by the Wald test.”
MethodDioxin-induced Immortalization of Normal Human Keratinocytes and Silencing of p53 and p16INK4a
Ray, S. S., & Swanson, H. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402771200 · Cited by 82
Expression and significance of histone H3K27 demethylases in renal cell carcinoma
Shen, Y., Guo, X., Wang, Y., Qiu, W., Chang, Y., Zhang, A., & Duan, X. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-470 · Cited by 89
“p14ARF inhibits the activity of p53-specific ubiquitin ligase murine double minute 2 (MDM2), which increases expression of p53 protein [30].”
BackgroundIs DNA damage indispensable for stress-induced senescence?
Bielak-Żmijewska, A., Mosieniak, G., & Sikora, E. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.08.004 · Cited by 92
Senescence As an Anticancer Mechanism
Hornsby, P. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.3101 · Cited by 90
Bone Marrow-Derived Cells: The Influence of Aging and Cellular Senescence
Beausejour, C. M. (2007) · Springer eBooks · doi:10.1007/978-3-540-68976-8_4 · Cited by 89
“This danger was counteracted by the evolution of tumor-suppressor mechanisms ( Campisi 2003, 2005 ).”
BackgroundCellular Senescence in Lung Fibrosis
Hernandez-Gonzalez, F., Faner, R., Rojas, M., Agustí, A., Serrano, M., & Sellarés, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137012 · Cited by 76
Is cellular senescence an example of antagonistic pleiotropy?
Giaimo, S., & d’Adda di Fagagna, F. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00807.x · Cited by 77
“allele might be regarded as a potential bias in the proposed method, as apoptosis has also been proposed to be a case of antagonistic pleiotropy for reasons analogous to cellular senescence (Campisi, 2003) – ‘early in life, apoptosis is an anticancer mechanism; late in life, as stem cells no”
BackgroundMethodInfluentialTargeting metabolism in cellular senescence, a role for intervention
Nacarelli, T., & Sell, C. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.049 · Cited by 85
p53: guardian AND suppressor of longevity?
Donehower, L. A. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.10.007 · Cited by 82
The evolution and expression of virulence
Ebert, D., & Bull, J. J. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0012 · Cited by 82
Shankar, S. (2010) · Indian Journal of Pathology and Microbiology · doi:10.4103/0377-4929.71995 · Cited by 72
Inhibitory role of peroxiredoxin II (Prx II) on cellular senescence
Han, Y., Kim, H.-S., Kim, J., Kim, S., Yu, D., & Moon, E. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.07.049 · Cited by 74
“tured cells, the process may also be important in aging and cancer [2,7].”
BackgroundRavelojaona, V., Robert, A. M., & Robert, L. (2008) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2007.12.004 · Cited by 73
Destructive cycles: the role of genomic instability and adaptation in carcinogenesis
Schneider, B. L., & Kulesz-Martin, M. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh204 · Cited by 83
p53: at the crossroad between cancer and ageing
Papazoglu, C., & Mills, A. (2007) · The Journal of Pathology · doi:10.1002/path.2086 · Cited by 72
“The ‘gatekeeper genes’, which include genes responsible for cell death and cell cycle arrest, include the classic tumour suppressor genes [3].”
BackgroundRole of IFI 16 in cellular senescence of human fibroblasts
Xin, H., Pereira‐Smith, O. M., & Choubey, D. (2004) · Oncogene · doi:10.1038/sj.onc.1207836 · Cited by 81
“Accumulating data suggest that the irreversible cell growth arrest associated with cellular senescence represents a major barrier, which cells must circumvent to become malignant (Campisi, 2001, 2003).”
BackgroundLian, X. J., & Gallouzi, I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806372200 · Cited by 83
Calibration of Disease Simulation Model Using an Engineering Approach
Kong, C. Y., McMahon, P. M., & Gazelle, G. S. (2009) · Value in Health · doi:10.1111/j.1524-4733.2008.00484.x · Cited by 70
Effects of dietary restriction on hematopoietic stem-cell aging are genetically regulated
Ertl, R. P., Chen, J., Astle, C. M., Duffy, T. M., & Harrison, D. E. (2008) · Blood · doi:10.1182/blood-2007-01-069807 · Cited by 70
DNA Damage, Somatic Aneuploidy, and Malignant Sarcoma Susceptibility in Muscular Dystrophies
Schmidt, W. M., Uddin, M. H., Dysek, S., Moser-Thier, K., Pirker, C., Höger, H., Ambros, I. M., Ambros, P. F., Berger, W., & Bittner, R. E. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002042 · Cited by 81
The aged nonhematopoietic environment impairs natural killer cell maturation and function
Shehata, H. M., Hoebe, K., & Chougnet, C. A. (2015) · Aging Cell · doi:10.1111/acel.12303 · Cited by 69
“In addition, the elderly are highly susceptible to the development of tumors with the incidence of cancer being particularly high in individuals aged > 60 years (Campisi, 2003; Jemal et al., 2010).”
Backgroundvan Heemst, D., den Reijer, P. M., & Westendorp, R. G. J. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.07.011 · Cited by 87
Waskar, M., Landis, G. N., Shen, J., Curtis, C. N., Tozer, K. R., Abdueva, D. A., Skvortsov, D., Tavaré, S., & Tower, J. (2009) · Aging · doi:10.18632/aging.100099 · Cited by 79
“Based on studies in mammals it has been suggested that p53 may exhibit antagonistic pleiotropy between life-cycle stages, in that it favors normal development, fecundity and cancer resistance in young animals, but may promote aging in old animals [9, 13-15].”
BackgroundEarly Life Exposure to the 1918 Influenza Pandemic and Old-Age Mortality by Cause of Death
Myrskylä, M., Mehta, N. K., & Chang, V. W. (2013) · American Journal of Public Health · doi:10.2105/ajph.2012.301060 · Cited by 67
Cancer: A disease at the crossroads of trade‐offs
Jacqueline, C. M., Biro, P. A., Beckmann, C., Møller, A. P., Renaud, F., Sorci, G., Tasiemski, A., Újvári, B., & Thomas, F. (2016) · Evolutionary Applications · doi:10.1111/eva.12444 · Cited by 78
“Finally, the p53 protein, with a well- known cancersuppressive function, leads to reduced tissue renewal and repair, stem cell deletion, and organismal aging through an antagonistic pleiotropy effect (Campisi, 2002, 2003; García- Cao et al., 2002).”
BackgroundStress granules counteract senescence by sequestration of PAI‐1
Omer, A., Patel, D. M., Lian, X. J., Sadek, J., Marco, S. D., Pause, A., Gorospe, M., & Gallouzi, I. (2018) · EMBO Reports · doi:10.15252/embr.201744722 · Cited by 71
Zhang, L., Zeng, H., & Cheng, W. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.05.067 · Cited by 68
Chen, C., Lu, Z., Yang, J., Hao, W.-C., Qin, Y., Wang, H., Xie, C., & Xie, R. (2016) · Cancer Medicine · doi:10.1002/cam4.863 · Cited by 65
Arthroplasty Utilization in the United States is Predicted by Age-Specific Population Groups
Bashinskaya, B., Zimmerman, R. M., Walcott, B. P., & Antoci, V. (2012) · ISRN Orthopedics · doi:10.5402/2012/185938 · Cited by 72
“With age, a cumulative “wear and tear” summates at the cellular, organ and population based levels [16–21].”
Książek, K., Mikuła‐Pietrasik, J., Catar, R. A., Dworacki, G., Winckiewicz, M., Frydrychowicz, M., Dragun, D., Staniszewski, R., Jörres, A., & Witowski, J. (2009) · International Journal of Cancer · doi:10.1002/ijc.25036 · Cited by 67
The DNA damage response: balancing the scale between cancer and ageing.
Seviour, E. G., & Lin, S.-Y. (2010) · Aging · doi:10.18632/aging.100248 · Cited by 61
Yang, Y.-C., Fu, H., Wu, C., Wei, K.-T., Huang, K., & Kang, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079434 · Cited by 65
Telomere dysfunction and its role in haematological cancer
Jones, C. H., Pepper, C. J., & Baird, D. M. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.09022.x · Cited by 66
“Telomere erosion and replicative senescence/apoptosis therefore provides a limit to the replicative capacity of human cells and this is considered to provide an important tumour-suppressive mechanism (Campisi, 2003).”
BackgroundAvian senescence: underlying mechanisms
Vleck, C. M., Haussmann, M. F., & Vleck, D. B. V. (2007) · Journal für Ornithologie · doi:10.1007/s10336-007-0186-5 · Cited by 73
“…or not replicative senescence is a causal agent of aging in vivo is controversial, because cells in culture often suffer abnormal stress, and most cells in vivo probably do not divide often enough to erode telomeres significantly (Rubin 2002; Wright and Shay 2002; Campisi 2003; Patil et al. 2005).”
LncRNA-OIS1 regulates DPP4 activation to modulate senescence induced by RAS
Li, L., van Breugel, P. C., Loayza-Puch, F., Ugalde, A. P., Korkmaz, G., Messika-Gold, N., Han, R., Lopes, R., Barbera, E. P., Teunissen, H., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky087 · Cited by 60
Catabolic Insufficiency and Aging
TERMAN, A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1354.005 · Cited by 58
A connection between magnesium deficiency and aging: new insights from cellular studies.
Killilea, D. W., & Maier, J. A. M. (2008) · PubMed · Cited by 74
Cancer: a disease of the elderly.
Ershler, W. B. (2003) · PubMed · Cited by 64
The role of genetic variants in human longevity
Chung, W., Dao, R., Chen, L., & Chung, W. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.08.001 · Cited by 67
“Later, many studies assessed the function of P72R as well as the association between P72R allele and cancer risk, and they suggested that these two alleles have different biologic properties in their ability to bind components of the transcriptional machinery, leading to different risks for cancer development (Thomas…”
BackgroundAge-Dependent Usage of Double-Strand-Break Repair Pathways
Preston, C. R., Flores, C. C., & Engels, W. R. (2006) · Current Biology · doi:10.1016/j.cub.2006.08.058 · Cited by 63
Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERT
Röth, A., Baerlocher, G. M., Schertzer, M., Chavez, E., Dührsen, U., & Lansdorp, P. M. (2005) · Blood · doi:10.1182/blood-2004-10-4144 · Cited by 57
“When telomeric ends become too short, DNA damage signals from telomeres(4) can induce apoptosis or a state of replicative senescence and telomere shortening has been proposed to limit the proliferation of most human cells.(5) Telomeres shorten with each round of cell division as a result of failure to completely repli…”
BackgroundTargeting normal and cancer senescent cells as a strategy of senotherapy
Sikora, E., Bielak-Zmijewska, A., & Mosieniak, G. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100941 · Cited by 56
Sah, N. K., Singh, S. N. P., Sahdev, S., Banerji, S., Jha, V., Khan, Z., & Hasnain, S. E. (2005) · Journal of Biosciences · doi:10.1007/bf02703724 · Cited by 56
“( Campisi 2003; Friedlander 2003; Schmitt 2003; Zender and Kubicka 2004).”
BackgroundMutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers
Ferraiuolo, M. A., Verduci, L., Blandino, G., & Strano, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050961 · Cited by 56
Using Mice to Examine p53 Functions in Cancer, Aging, and Longevity
Donehower, L. A. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001081 · Cited by 55
“Cancer rates increase dramatically with age in both humans and mice (Balducci and Beghe 2001; Campisi 2003).”
BackgroundBonuccelli, G., Peiris‐Pagès, M., Ózsvári, B., Martinez‐Outschoorn, U., Sotgia, F., & Lisanti, M. P. (2016) · Oncotarget · doi:10.18632/oncotarget.14196 · Cited by 58
Premature senescence of mesothelial cells is associated with non-telomeric DNA damage
Książek, K., Passos, J. F., Olijslagers, S., Saretzki, G. C., Martin-Ruiz, C. M., & von Zglinicki, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.047 · Cited by 58
A polymorphism in the tumor suppressor p53 affects aging and longevity in mouse models
Zhao, Y., Wu, L., Yue, X., Zhang, C., Wang, J., Li, J., Sun, X., Zhu, Y., Feng, Z., & Hu, W. (2018) · eLife · doi:10.7554/elife.34701 · Cited by 57
Immunosenescence and lymphomagenesis
Mancuso, S., Carlisi, M., Santoro, M., Napolitano, M., Raso, S., & Siragusa, S. M. (2018) · Immunity & Ageing · doi:10.1186/s12979-018-0130-y · Cited by 57
Is chlamydial heat shock protein 60 a risk factor for oncogenesis?
Felice, V. D., David, S., Cappello, F., Farina, F., & Zummo, G. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4367-6 · Cited by 59
Akkaoui, J., Yamada, C., Duarte, C. L., Ho, A., Vardar‐Şengül, S., Kawai, T., & Movilă, A. (2020) · GeroScience · doi:10.1007/s11357-020-00258-1 · Cited by 63
Common gene signature of cancer and longevity
Budovsky, A., Tăcutu, R., Yanai, H., Abramovich, A., Wolfson, M., & Fraifeld, V. E. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.04.002 · Cited by 54
MicroRNAs in human skin ageing
Mancini, M., Lena, A. M., Saintigny, G., Mahé, C., Daniele, N. D., Melino, G., & Candi, E. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.04.003 · Cited by 60
Stroma and pancreatic ductal adenocarcinoma: An interaction loop
Luo, G., Long, J., Zhang, B., Liu, C., Xu, J., Ni, Q., & Yu, X. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.04.002 · Cited by 59
Stress‐induced responses of human skin fibroblasts in vitro reflect human longevity
Dekker, P., Maier, A. B., Van Heemst, D., De Koning‐Treurniet, C., Blom, J., Dirks, R. W., Tanke, H. J., & Westendorp, R. G. J. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00506.x · Cited by 53
“However, as proliferating cells can transform into cancer cells as a result of genomic damage, several protective mechanisms have evolved to prevent cells from becoming neoplastic (Campisi, 2003; van Heemst et al., 2007).”
BackgroundAging: gene silencing or gene activation?
Burzynski, S. R. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.06.010 · Cited by 62
“A number of excellent reviews and books have recently been written on this subject [5,10–12].”
BackgroundQuan, T., Qin, Z., Voorhees, J. J., & Fisher, G. J. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24179 · Cited by 53
“Age-dependent alterations in the dermal ECM also create a microenvironment that facilitates formation and growth of skin cancer [Weinstock, 1994; Khorramizadeh et al., 1999; Campisi, 2003].”
BackgroundGenomic Instability, Aging, and Cellular Senescence
BUSUTTIL, R. A., DOLLÉ, M., CAMPISI, J., & VIJGA, J. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1297.041 · Cited by 53
Self-citationActivation-induced and damage-induced cell death in aging human T cells
Sikora, E. (2015) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2015.03.011 · Cited by 51
Significance of Cellular Senescence in Aging and Cancer
Grimes, A., & Chandra, S. (2009) · Cancer Research and Treatment · doi:10.4143/crt.2009.41.4.187 · Cited by 67
“188 CANCER RESEARCH AND TREATMENT variations can affect the results by unbalancing and disrupting gene expression and cellular behavior (15-17).”
BackgroundBartling, B., Demling, N., Silber, R., & Simm, A. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0194oc · Cited by 59
“The development of epithelial tumors, such as lung carcinomas, is closely associated with human age ( 30 ).”
BackgroundMaas, K., Westfall, M., Pietenpol, J., Olsen, N. J., & Aune, T. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20931 · Cited by 51
The cell nucleus and aging: tantalizing clues and hopeful promises
Scaffidi, P., Gordon, L., & Misteli, T. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030395 · Cited by 50
“These observations on WS and the occurrence of genomic instability in premature aging diseases crystallize a tantalizing antagonism between aging and cancer [13].”
Demetris, A. J. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i22.3512 · Cited by 50
Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides
Li, G., Eller, M. S., Hanna, K., & Gilchrest, B. A. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.08.019 · Cited by 49
A New Development in Senescence
Banito, A., & Lowe, S. W. (2013) · Cell · doi:10.1016/j.cell.2013.10.050 · Cited by 50
López‐Lázaro, M. (2015) · Oncoscience · doi:10.18632/oncoscience.159 · Cited by 51
“Numerous observational studies have shown that age is the most important cancer risk factor [7,32-35].”
BackgroundAging and cancer cell biology, 2008
Campisi, J. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00383.x · Cited by 50
“That is, cellular responses to potentially oncogenic events that protect young organisms from early life cancer might – later in life – drive aging phenotypes and the development of age-related disease, including (ironically) late life cancers (Campisi, 2003).”
BackgroundSelf-citationEffect of stem cell turnover rates on protection against cancer and aging
Wodarz, D. (2006) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2006.10.013 · Cited by 47
Sun, B., Chen, M., Hawks, C. L., Pereira‐Smith, O. M., & Hornsby, P. J. (2005) · Neoplasia · doi:10.1593/neo.05172 · Cited by 52
“Discussion The human diploid fibroblast has long been popular in studies of neoplastic transformation because of its ease of isolation from human subjects and its central role in understanding replicative senescence and crisis [25,26].”
BackgroundSenescence and Apoptosis: Architects of Mammalian Development
Wanner, E., Thoppil, H., & Riabowol, K. T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.620089 · Cited by 59
“While this remains widely accepted, a solely beneficial mechanism was later proposed in which senescence served as a first line of defense against cancers by limiting their growth (Campisi, 2003).”
BackgroundInfluentialAging-associated accumulation of mitochondrial DNA mutations in tumor origin
Kong, M., Guo, L., Xu, W., He, C., Jia, X., Zhao, Z., & Gu, Z. (2022) · Life Medicine · doi:10.1093/lifemedi/lnac014 · Cited by 53
Kajstura, J., Bolli, R., Sonnenblick, E. H., Anversa, P., & Leri, A. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.12.013 · Cited by 53
Effros, R. B. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0508-x · Cited by 47
Endostatin and kidney fibrosis in aging: a case for antagonistic pleiotropy?
Lin, C. H. S., Chen, J., Ziman, B. D., Marshall, S. A., Maizel, J., & Goligorsky, M. S. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00064.2014 · Cited by 51
Barajas-Gómez, B. A., Rosas‐Carrasco, Ó., Morales-Rosales, S. L., Pedraza-Vázquez, G., González‐Puertos, V. Y., Juárez‐Cedillo, T., García, J. A., López‐Díazguerrero, N. E., Damián‐Matsumura, P., Königsberg, M., et al. (2016) · Cytokine · doi:10.1016/j.cyto.2016.12.001 · Cited by 53
Gene polymorphisms, apoptotic capacity and cancer risk
Имянитов, Е. Н. (2009) · Human Genetics · doi:10.1007/s00439-009-0636-7 · Cited by 46
“…exempliWes a complex trade-oV between cancer risk and healthy aging: high cell proliferation, resistance to apoptosis, and active angiogenesis are likely to improve chances for longevity, but at the cost of increased probability of tumor development (Campisi 2003; Donehower 2005; Imyanitov 2009).”
Pathogen evolution in a vaccinated world
Read, A. F., & Mackinnon, M. J. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0011 · Cited by 50
Altered senescence, apoptosis, and DNA damage response in a mutant p53 model of accelerated aging
Hinkal, G. W., Gatza, C. E., Parikh, N., & Donehower, L. A. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.01.001 · Cited by 45
“The ability of tumor suppressors to induce apoptosis and senescence in response to cellular stress may play a role in the development of aging pathologies, as alterations in apoptosis and senescence have been associated with aging (Campisi, 2003; Serrano and Blasco, 2007).”
BackgroundUnderstanding the link between cancer and neurodegeneration
Driver, J. A. (2011) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2011.11.007 · Cited by 47
Role of Telomerase in Hematopoietic Stem Cells
LANSDORP, P. M. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1349.027 · Cited by 45
Expression of an IFN-Inducible Cellular Senescence Gene, IFI16, Is Up-Regulated by p53
Song, L. L., Alimirah, F., Panchanathan, R., Xin, H., & Choubey, D. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0208 · Cited by 47
“of normal cells to proliferate and preserves genomic integrity by preventing cells with short telomeres from entering the cell cycle (2, 3, 7).”
BackgroundAn association of Hutchinson–Gilford progeria and malignancy
Shalev, S. A., Sandre‐Giovannoli, A. D., Shani‐Adir, A., & Lévy, N. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31803 · Cited by 47
“These mutations tend to be those that inactivate either the p53 or Rb pathways [Campisi, 2003], which are perturbed as well in patients carrying primary or secondary lamin A alterations.”
BackgroundSTING SNP R293Q Is Associated with a Decreased Risk of Aging-Related Diseases
Hamann, L., Ruiz-Moreno, J. S., Szwed, M., Mossakowska, M., Lundvall, L., Schumann, R. R., Opitz, B., & Puzianowska-Kuznicka, M. (2019) · Gerontology · doi:10.1159/000492972 · Cited by 43
Mandir, N., Fitzgerald, A. J., & Goodlad, R. A. (2005) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2005.00422.x · Cited by 43
“The shift from developmental maintenance to somatic maintenance may, thus, have evolved at a cost (Campisi 2003).”
BackgroundThe ecology and evolution of antibiotic-resistant bacteria
Bergstrom, C. T., & Feldgarden, M. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0010 · Cited by 50
Role of 2-5A-dependent RNase-L in senescence and longevity
Andersen, J. B., Li, X. L., Judge, C. S., Zhou, A., Jha, B. K., Shelby, S., Zhou, L., Silverman, R. H., & Hassel, B. A. (2006) · Oncogene · doi:10.1038/sj.onc.1210111 · Cited by 49
“Indeed, the same genes that mediate senescence also function in tumor suppression (Campisi, 2003; Shay and Roninson, 2004), providing a mechanistic link between cancer, long known to be an age-associated disease and aging.”
InfluentialThe evolution of multicellularity and cancer: views and paradigms
Nedelcu, A. M. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190992 · Cited by 48
A quantitative model for age-dependent expression of the p16INK4a tumor suppressor
Tsygankov, D., Liu, Y., Sanoff, H. K., Sharpless, N. E., & Elston, T. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904405106 · Cited by 42
Aging stem cells, latexin, and longevity
Liang, Y., & Zant, G. E. V. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.01.032 · Cited by 50
Metadata
- Authors
- Campisi, J.
- Affiliations
- Lawrence Berkeley National Laboratory (US)
- Corresponding author
- Campisi, Judith
- ORCID
- Campisi, Judith
- Venue
- Nature Reviews Cancer
- Published
- 2003-05
- Volume
- 3
- Issue
- 5
- Pages
- 339-349
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2096846805
- Cited by
- 512
- References
- 158
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 9 · 2023: 12 · 2022: 14 · 2021: 15 · 2020: 10 · 2019: 10 · 2018: 18 · 2017: 19 · 2016: 16 · 2015: 23 · 2014: 20 · 2013: 19 · 2012: 23
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- cancer, aging, tumor suppressor pathways, somatic maintenance, embryonic development
- MeSH terms
- Aging, DNA Repair, Humans, Longevity, Neoplasms, Tumor Suppressor Protein p53, Retinoblastoma Protein, Cellular Senescence, Apoptosis, Genomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.